244 DIAGNOSTIC AND PROGNOSTIC ROLE OF SCCA-IGM IN HEPATOCELLULAR CARCINOMA (HCC)
β Scribed by C. Pozzan; R. Cardin; N. Cazzagon; M. Picciocchi; V. Vanin; A. Giacomin; A. Sergio; P. Pontisso; F. Farinati
- Book ID
- 117379390
- Publisher
- Elsevier Science
- Year
- 2011
- Tongue
- English
- Weight
- 40 KB
- Volume
- 54
- Category
- Article
- ISSN
- 0168-8278
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Ξ±-Feto protein (AFP) is the widely used tumor marker in the diagnosis of hepatocellular carcinoma (HCC). The aim of this study was to assess the diagnostic and prognostic validity of a novel marker, serum Glypican-3 (GPC3) and to compare AFP in patients with HCC. One hundred and twenty-eight patient
## Abstract Hepatocellular carcinoma (HCC) is the fifth most frequent cancer in the world and a common occurrence in patients with liver cirrhosis in western and North American countries. Ultrasound screening is a powerful technique for HCC diagnosis, whereas the only available serologic test, alph